Thyroid surgery for Graves' disease and Graves' ophthalmopathy

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 11, 2015, Pages

  Liu, Zi Wei ^a   Masterson, Liam ^b   Fish, Brian ^b   Jani, Piyush ^b   Chatterjee, Krishna ^b  

^a WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE ASSOCIATION; ENDOCRINE OPHTHALMOPATHY; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOPARATHYROIDISM; INTENTION TO TREAT ANALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; RECURRENT LARYNGEAL NERVE PALSY; REVIEW; RISK ASSESSMENT; SOCIAL STATUS; SUBTOTAL THYROIDECTOMY; SYSTEMATIC REVIEW; THYROIDECTOMY; TREATMENT OUTCOME; ADVERSE EFFECTS; GRAVES OPHTHALMOPATHY; META ANALYSIS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REOPERATION; SECONDARY PREVENTION;

GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; REMISSION INDUCTION; REOPERATION; SECONDARY PREVENTION; THYROIDECTOMY;

EID: 84964695318     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010576.pub2     Document Type: Review

References (74)

1. Barczyński M, Konturek A, Hubalewska-Dydejczyk A, Gołkowski F, Nowak W. Randomized clinical trial of bilateral subtotal thyroidectomy versus total thyroidectomy for Graves' disease with a 5-year follow-up. British Journal of Surgery 2012;99(4):515-22.
2. Niederle B. Randomized clinical trial of bilateral subtotal thyroidectomy versus total thyroidectomy for Graves' disease with a 5-year follow-up. British Journal of Surgery 2012; Vol. 99:515-22.
3. Chi SY, Hsei KC, Sheen-Chen SM, Chou FF. A prospective randomized comparison of bilateral subtotal thyroidectomy versus unilateral total and contralateral subtotal thyroidectomy for graves' disease. World Journal of Surgery 2005;29(2):160-3.
4. Jarhult J, Rudberg C, Larsson E, Selvander H, Sjövall K, Winsa B, et al. TEO Study Group. Graves' disease with moderate-severe endocrine ophthalmopathy-long term results of a prospective, randomized study of total or subtotal thyroid resection. Thyroid 2005;15(10):1157-64.
5. Müller PE, Bein B, Robens E, Bein HS, Spelsberg F. Thyroid surgery according to Enderlen-Hotz or Dunhill: a comparison of two surgical methods for the treatment of Graves' disease. International Surgery 2001;86(2):112-6.
6. Witte J, Goretzki PE, Dotzenrath C, Simon D, Felis P, Neubauer M, et al. Surgery for Graves' disease: total versus subtotal thyroidectomy-results of a prospective randomized trial. World Journal of Surgery 2000;24(11):1303-11.
7. Abe Y, Sato H, Noguchi M, Mimura T, Sugino K, Ozaki O, et al. Effect of subtotal thyroidectomy on natural history of ophthalmopathy in graves' disease. World Journal of Surgery 1998;22:714-17.
8. Al-Adhami A, Craig W, Krukowski ZH. Quality of life after surgery for graves' disease:Comparison of those having surgery intended to preserve thyroid function with those having ablative surgery. Thyroid 2012;22:494-500.
9. Barakate MS, Agarwal G, Reeve TS, Barraclough B, Robinson B, Delbridge LW. Total thyroidectomy is now the preferred option for the surgical management of graves' disease. ANZ Journal of Surgery 2002;72:321-24.
10. Boostrom S, Richards ML. Total thyroidectomy is the preferred treatment for patients with Graves' disease and a thyroid nodule. Otolaryngology - Head and Neck Surgery 2007;136:278-81.
11. Campos Pastor MM, Fernandez Soto ML, Escobar-Jimenez F, Barredo Acedo F, Ruiz de Almodovar M. Long-term evolution of immunologic and thyroid function in Graves disease according different therapeutic options. [Spanish] [Evolucion inmunologica y de la funcion tiroidea a largo plazo en la enfermedad de Graves segun distintas opciones terapeuticas]. Medicina clinica 1994;102:446-50.
12. Candela G, Varriale S, Di Libero L, Maschio A, Giordano M, Manetta F, et al. Nearly total thyroidectomy: Versus total thyroidectomy: Our experience [Tiroidectomia quasi totale versus tiroidectomia totale: Nostra esperienza]. Minerva Chirurgica 2006;61:17-24.
13. De Bellis A, Conzo G, Cennamo G, Pane E, Bellastella G, Colella C, et al. Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: A 2-year longitudinal study. Endocrine 2012;41:320-6.
14. Fernandez Sanchez JR, Rosell Pradas J, Carazo Martinez O, Torres Vela E, Escobar Jimenez F, Garbin Fuentes I. Graves' ophthalmopathy after subtotal thyroidectomy and radioiodine therapy. British Journal of Surgery 1993;80:1134-6.
15. Feroci F, Rettori M, Borrelli, A, Coppola A, Castagnoli A, Perigli, G, et al. A systematic review and meta-analysis of total thyroidectomy versus bilateral subtotal thyroidectomy for Graves' disease. Surgery 2014;155:529-40.
16. Guo Z, Yu P, Liu Z, Si Y, Jin M. Total thyroidectomy vs bilateral subtotal thyroidectomy in patients with Graves' diseases: A meta-analysis of randomized clinical trials. Clinical Endocrinology 2013;79:739-46.
17. Hughes OR, Scott-Coombes DM. Hypocalcaemia following thyroidectomy for treatment of Grave's disease: Implications for patient management and cost-effectiveness. Journal of Laryngology and Otology 2011;125:849-52.
18. Hussain M, Hisham AN. Total thyroidectomy: The procedure of choice for toxic goitre. Asian Journal of Surgery 2008;31:59-62.
19. Jarhult J, Andersson PO, Duncker L. Alternating from subtotal thyroid resection to total thyroidectomy in the treatment of Graves' disease prevents recurrences but increases the frequency of permanent hypoparathyroidism. Langenbeck's Archives of Surgery 2012;397:407-12.
20. Jukic T, Stanicic J, Petric V, Kusic Z. Radioiodine versus surgery in the treatment of Graves' hyperthyroidism [Radioaktivni jod-131 ili kirurski zahvat u lijecenju Gravesove hipertireoze (Croatian)]. Lijecnicki vjesnik 2010;132:355-60.
21. Khadra M, Delbridge L, Reeve TS, Poole AG, Crummer P. Total thyroidectomy: its role in the management of thyroid disease. The Australian and New Zealand Journal of Surgery 1992;62:91-5.
22. Ku CF, Lo CY, Chan WF, Kung AWC, Lam KSL. Total thyroidectomy replaces subtotal thyroidectomy as the preferred surgical treatment for Graves' disease. ANZ Journal of Surgery 2005;75:528-31.
23. Kurihara H. Total thyroidectomy for the treatment of hyperthyroidism in patients with ophthalmopathy. Thyroid 2002;12:265-7.
24. Leo M, Marcocci C, Pinchera A, Nardi M, Megna L, Rocchi R, et al. Outcome of Graves' orbitopathy after total thyroid ablation and glucocorticoid treatment:follow-up of a randomized clinical trial. Journal of Clinical Endocrinology & Metabolism 2012;97:E44-8.
25. Lepner U, Seire I, Palmiste V, Kirsimagi U. Surgical treatment of Graves' disease: subtotal thyroidectomy might still be the preferred option. Medicina (Kaunas, Lithuania) 2008;44:22-6.
26. Ljunggren JG, Torring O, Wallin G, Taube A, Tallstedt L, Hamberger B, et al. Quality of life aspects and costs in treatment of Graves' hyperthyroidism with antithyroid drugs, surgery, or radioiodine: results from a prospective, randomized study. Thyroid 1998;8:653-9.
27. Lofthouse M. Subtotal versus total thyroidectomy for patients with Graves' eye disease. Nature Clinical Practice Endocrinology and Metabolism 2006;2:63-4.
28. Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Pinchera A. Relationship between Graves'ophthalmopathy and type of treatment of Graves' hyperthyroidism. Thyroid 1992;2:171-8.
29. Maschuw K, Schlosser K, Sitter H, Bartsch DK. Total versus near-total thyroidectomy in Graves'disease (TONIG) - A potential prospective randomized controlled multicentered trial of the CAEK society. Langenbeck's Archives of Surgery 2011;396(8):1300.
30. Menconi F, Marino M, Pinchera A, Rocchi R, Mazzi B, Nardi M, et al. Effectsof total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids. Journal of Clinical Endocrinology & Metabolism 2007;92:1653-8.
31. Miccoli P, Vitti P, Rago T, Iacconi P, Bartalena L, Bogazzi F, et al. Surgical treatment of Graves' disease: Subtotal or total thyroidectomy?. Surgery 1996;120:1020-5.
32. Morosini PP, Fianchini A, Landi E. Surgical treatment of hyperthyroidism: total thyroidectomy versus subtotal thyroidectomy [Italian] [La terapia chirurgica dell'ipertiroidismo: tiroidectomia totale "versus" tiroidectomia subtotale]. Giornale di chirurgia 1988;9:210-2.
33. Robert J, Mariethoz S, Pache JC, Bertin D, Caulfield A, Murith N, et al. Short- and long-term results of total vs subtotal thyroidectomies in the surgical treatment of Graves' disease. Swiss Surgery 2001;7:20-4.
34. Rosato L, Avenia N, De Palma M, Gulino G, Nasi PG, Pezzullo L. Complications of total thyroidectomy: incidence, prevention and treatment [Complicanze della tiroidectomia totale: incidenza, prevenzione e trattamento (Italian)]. Chirurgia italiana 2002;54:635-42.
35. Sánchez J, Lamata F, Lagos J, Cerdán R, García FA, Martínez M, et al. Total versus subtotal thyroidectomy in the surgical treatment of Graves' disease. Cirugía Española 1999;65(2):110-5.
36. Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ito K. Surgical management of Graves' disease -10-year prospective trial at a single institution. Endocrine Journal 2008;55:161-7.
37. Tallstedt L, Lundell G, Torring O, Wallin G, Ljunggren JG, Blomgren H, et al. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group. New England Journal of Medicine 1992;326:1773-8.
38. Tallstedt L, Lundell G. Radioiodine treatment, ablation, and ophthalmopathy: a balanced perspective. Thyroid 1997;7:241-5.
39. Tian JL, Chen SF, Du YH, Li CL, Wang W, Li YS, et al. A comparative study of the long-term effect of thyroid arterial embolization with surgical thyroidectomy in treating Graves' disease. Journal of Interventional Radiology (China) 2012;21:194-7.
40. Torring O, Tallstedt L, Wallin G, Lundell G, Ljunggren JG, Taube A, et al. Graves' hyperthyroidism: Treatment with antithyroid drugs, surgery, or radioiodine - A prospective, randomized study. Journal of Clinical Endocrinology and Metabolism 1996;81:2986-93.
41. Welch KC, McHenry CR. Total thyroidectomy: Is morbidity higher for graves' disease than non-toxic goiter?. Journal of Surgical Research 2011;170:96-9.
42. Woods R. Total thyroidectomy versus bilateral subtotal thyroidectomy in patients with Graves' diseases: A meta-analysis of randomized clinical trials. Clinical Endocrinology 2014;80(2):316.
43. Yalcin Y, Topaloglu O, Berker D, Isik S, Guler S. Evaluation of therapeutic modalities in Graves' hyperthyroidism. Endocrine Abstracts 2010;22:815.
44. Zaraca F, Di Paola M, Gossetti F, Proposito D, Filippoussis P, Montemurro L, et al. Benign thyroid disease: 20-year experience in surgical therapy. [Italian] [Malattia tiroidea benigna: esperienza ventennale di terapia chirurgica]. Chirurgia italiana 2000;52:41-7.
45. Maschuw K, Schlosser K, Lubbe D, Nies C, Bartsch DK. Total versus near-total thyroidectomy in Graves' disease and their outcome on postoperative transient hypoparathyroidism: study protocol for a randomized controlled trial?. Trials 2012;13:234. [DOI: 10.1186/1745-6215-13-234]
46. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. https://www.aace.com/files/hyper-guidelines-2011.pdf (accessed 26 June 2015).
47. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490.
48. Barczyński M, Konturek A, Stopa M, Cichoń S, Richter P, Nowak W. Total thyroidectomy for benign thyroid disease: is it really worthwhile?. Annals of Surgery 2011;254(5):724-9. [PUBMED: 22005150]
49. Bellantone R, Lombardi CP, Bossola M, Boscherini M, De Crea C, Alesina P. Total thyroidectomy for management of benign thyroid disease: review of 526 cases. World Journal of Surgery 2002;26(12):1468-71. [PUBMED: 12360381]
50. Beller EM, Chen JK, Wang UL, Glasziou PP. Are systematic reviews up-to-date at the time of publication?. Systematic Reviews 2013;2:36. [2046-4053: (Electronic)]
51. Brandt F, Green A, Hegedüs L, Brix TH. A critical review and meta-analysis of the association between overt hyperthyroidism and mortality. European Journal of Endocrinology/European Federation of Endocrine Societies 2011;165(4):491-7. [PUBMED: 21724839]
52. Efremidou EI, Papageorgiou MS, Liratzopoulos N, Manolas KJ. The efficacy and safety of total thyroidectomy in the management of benign thyroid disease: a review of 932 cases. Canadian Journal of Surgery 2009;52(1):39-44. [PUBMED: 19234650]
53. Genovese BM, Noureldine SI, Gleeson EM, Tufano RP, Kandil E. What is the best definitive treatment for Graves' disease? A systematic review of the existing literature. Annals of Surgical Oncology 2012;20(2):660-7. [DOI: 10.1245/s10434-012-2606-x]
54. McMaster University (developed by Evidence Prime, Inc.). GRADEproGDT: GRADEpro Guideline Development Tool [www.guidelinedevelopment.org]. Hamilton: McMaster University (developed by Evidence Prime, Inc.), 2015.
55. Hermann M, Roka R, Richter B, Freissmuth M. Early relapse after operation for Graves' disease: postoperative hormone kinetics and outcome after subtotal, near-total, and total thyroidectomy. Surgery 1998;124(5):894-900. [: 9823404]
56. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21:1539-58.
57. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003;327:557-60.
58. Higgins JPT, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. Journal of the Royal Statistical Society: Series A (Statistics in Society) 2009;172(1):137-59.
59. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
60. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
61. Hróbjartsson A, Thomsen AS, Emanuelsson F, Tendal B, Hilden J, Boutron I, et al. Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors. Canadian Medical Association Journal 2013;185(4):E201-11.
62. In H, Pearce EN, Wong AK, Burgess JF, McAneny DB, Rosen JE. Treatment options for Graves disease: a cost-effectiveness analysis. Journal of the American College of Surgeons 2009;209(2):170-9. [PUBMED: 19632593]
63. Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010;340:c365. [DOI: 10.1136/bmj.c365]
64. Lalwani K. Lange Current Diagnosis and Treatment: Otolaryngology - Head and Neck Surgery. 3rd Edition. McGraw-Hill, 2012.
65. Laurberg P, Berman DC, Bülow Pedersen I, Andersen S, Carlé A. Incidence and clinical presentation of moderate to severe graves' orbitopathy in a Danish population before and after iodine fortification of salt. Journal of Clinical Endocrinology and Metabolism 2012;97(7):2325-32. [PUBMED: 22518849]
66. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
67. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic and meta-analyses of studies that evaluate interventions: explanation and elaboration. PLoS Medicine 2009;6(7):1-28. [DOI: 10.1371/journal.pmed.1000100]
68. Palit TK, Miller CC 3rd, Miltenburg DM. The efficacy of thyroidectomy for Graves' disease: a meta-analysis. Journal of Surgical Research 2000;90(2):161-5. [PUBMED: 10792958]
69. Ponto Ka, Kahaly GJ. Autoimmune thyrotoxicosis: diagnostic challenges. American Journal of Medicine 2012;125(9):S1. [PUBMED: 22938935]
70. Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ 2011;342:d549.
71. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:d4002.
72. Wong SSL, Wilczynski NL, Haynes RB. Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE. Journal of the Medical Library Association 2006;94(1):41-7.
73. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008;336(7644):601-5.
74. Zanocco K, Heller M, Elaraj D, Sturgeon C. Is subtotal thyroidectomy a cost-effective treatment for Graves disease? A cost-effectiveness analysis of the medical and surgical treatment options. Surgery 2012;152(2):164-72. [PUBMED: 22503512]